Regencell Bioscience (RGC)
(Delayed Data from NSDQ)
$12.60 USD
-0.86 (-6.39%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $12.90 +0.30 (2.38%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, Regencell Bioscience Holdings Limited has a market cap of $11.37B, which represents its share price of $22.99 multiplied by its outstanding shares number of 494.49M. As a large-cap company, RGC's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
RGC 12.60 -0.86(-6.39%)
Will RGC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RGC based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for RGC
Largest borrow rate increases among liquid names
Regencell Bioscience (RGC) Shares Surge Over 27% | RGC Stock News
Regencell Bioscience rises 27.4%
ClearBridge Small Cap Strategy Q2 2025 Commentary
Regencell Bioscience (RGC) Prepares for Potential Post-Earnings Movement | RGC Stock News